Turn Your $1,000 Into Over 2 Million Dollars With Their Help  at
http://www.stocksmastermind.com

Turn Your $1,000 Into Over 2 Million Dollars With Their Help  at
http://www.stocksmastermind.com

Dear Friends :

SINOBIOPHRMA INC "soared" 93% with two trading Days after my alert !
Congratulations!!!

Today SINOBIOPHRMA INC traded as high of  0.39 on over 5,000,000
shares traded

I gave this to you at 0.20 for Monday's trade....

Ok, so what’s next you ask? I have something even bigger...

Why it's in your best interest to buy  and Full Presentation on Entest
BioMedical Inc

Bio-tech companies are a great investment right now, according to many
financial experts. Support from the Obama administration will ensure
this trend continues.

Between the current administration rallying behind Bio-tech and
Stimulus plan. This is a great combo to ensure if you pick the right
Bio-tech stock you can make massive gains quickly.

"WALL STREET IS ALWAYS LOOKING” For the Next Big Thing.......

Whether it's a cure for cancer or a fountain of youth , the script
can be all-too-familiar Financially, 2009 has been a hard year.

Almost every industry sector has suffered....

But financial experts wouldn't be experts if they couldn't find a
sector that will do better than the others, and that will offer
substantial returns

to investors.

Biotech is what they recommend

Forbes interviewed two top-notch analysts in this area, Eric Schmidt
and Ross Muken. They both agree that there is money to be made by
investing in biotech.

Bottom line is this... You have a choice,

You can take action and buy Entest BioMedical Inc now!
or wait to buy it at potentially $3.50 per share

This is set to soar!!

Exploder

Turn Your $1,000 Into Over 2 Million Dollars With Their Help  at
http://www.stocksmastermind.com

Turn Your $1,000 Into Over 2 Million Dollars With Their Help  at
http://www.stocksmastermind.com

Dear Friends:

SNBP is our New Pick www.sinobiopharma.com

SINO BIOPHARMA SNBP a Fully integrated specality biopharmaceutical
company with 30,000 sq.meter Certified Production Facilities in China.

Estimated Chinese Health Care Market Demand of $600 Billion by 2015.We
all are aware China’s Current population is 1.4 Billion.

SNBP traded as high as $2.0 in the PAST, we can shoot for a gain of
8400%

Leadership of CEO Dr. Lequn Lee Huang a former manager of the Bayer
Co., one of the world's largest pharmaceutical companies and CFO Mr.
Dong Ying formerly of JP Morgan Chase.

SNBP Anesthetics Projected sale of 1.5 million units and 500,000
tablets for cardiovascular diseases in 2009.

Key Drives:
Outstanding financial results; more than 2000% growth in 3 years.
4 key marketed products; multiple products in pipeline.
R&D Partnership with Cornell University and 3 Top Universities in
China.
Established Nation wide Sales and Marketing Network in China.
Aging Population & Increasing Life Style diseases.
Improving Health Insurance Programs and Coverage.

PLAN FOR FUTURE: Sinobiopharma has a clearly defined strategy to drive
short, middle and long term growth.  All drug development will
leverage the Company's patented technology for fast, low-cost drug
synthesis and new technology for formulation.

Check out Complete Presentation only at www.stockexploder.com
Please do your own due diligence on SNBP
All The Best

Exploder

www.stockexploder.com
 *Never invest in a stock mentioned by stockexploder.com unless you
can afford to lose your entire investment. For full disclaimer
http://www.stockexploder.com/disclaimer.html

These market profile numbers act as great support/ resistance areas
intraday.

Here are the numbers for Monday September 21

Value area high:  74.30

Point of Control:  73.90

Value area low:  73.50

I get these numbers from here:  sandp500analysis com

Thanks for the link, i also like http://www.boardcentral.com/twitter/GOLD
to see what else is out there and what people say.

SPAM

SPAM

SPAM

A bot to project the short term of the market ain't that bad of an
idea if you already are consulting a shaman to know the forecast of
the next week. I don't say that the bot ain't efficient to recognise
patterns it already saw by the past, it's just that predicting future
is an almost impossible thing to do if you don't consider an unnatural
approche. The bot might be able to explain why is a stock where it is
now but it doesn't see the future and therefore, you can't just thrust
the prediction that if you hold a rock and let it go it will
automaticaly go down on the ground with the gravity. (I know matrix
quote but hey ...).

On 29 mai, 17:30, Cancer <cancerma...@gmail.com> wrote:

The Web Bot Project has made many accurate and insightful predictions
regarding future events. It was created to track stock market trends
back in the 1990’s. The Web Bot uses a system of spiders that crawl
the Internet looking for predictable patterns of behavior, trends and
chatter pertaining to future events. Look what is instore this year.

http://stockmarketwebbot.blogspot.com/

“Summer of Hell” Web bot prediction for financial markets.  It will
make a believer out of you.

http://stockmarketwebbot.blogspot.com/

http://2009predictionwebbot.blogspot.com

On May 20, 7:40 pm, skillfulpeo...@gmail.com wrote:

Golden Eagle International (OTCBB:MYNG) is a company that explores,
produces and maintains gold mill operations in partnership with Yukon
Nevada Gold (TSX:YNG). Golden Eagle is an excellent target for junior
and mid-tier mining companies looking forward to increase the value of
their assets. The company's team is highly qualified and it has been
working steady since for years. The outlook for this stock is to go
up
1000% this year.

GEII has now improved the following ratios:

Acid Test or Quick Ratio: Current Assets - Inventories / Liabilities
Operating Cash Flow: Cash Flow from Oeprations / Current Liabilities
Debt/Equity Ratio: Total Debt/Book Value
Interest Coverage: Net Earnings / Total interest charges

It also has a better Gross Profit Margin and a better Operating Profit
Margin. It is now prepared to get a net return on the invested
Capital, and if that happens, the ROE or Return on Common With
expected revenues per full operating quarter of $1,168,000 equity in
this stock will seriously improve.